磷丙泊酚二钠的应用现状与研究进展
Fospropofol Disodium: Application Status and Research Progress
DOI: 10.12677/acm.2026.1672663, PDF,   
作者: 周思雨：吉首大学医学院，湖南 吉首；符 磊*：张家界市人民医院麻醉科，湖南 张家界
关键词: 磷丙泊酚二钠；丙泊酚；静脉麻醉药；镇静；围术期管理；Fospropofol Disodium； Propofol； Intravenous Anesthetic； Sedation； Perioperative Management
摘要: 磷丙泊酚二钠(fospropofol disodium)是我国自主研发的水溶性丙泊酚前体药物，目前已获批用于成人全身麻醉诱导与维持、重症监护病房(ICU)机械通气患者镇静及非气管插管诊疗操作镇静。该药经体内碱性磷酸酶水解释放活性代谢产物丙泊酚，具有起效相对平缓、血药浓度上升稳定等药代动力学特点。与传统脂肪乳剂型丙泊酚相比，其在降低注射痛发生率、减轻循环和呼吸抑制方面具有一定优势。然而，该药仍存在起效时间延长、感觉异常及瘙痒发生率较高等问题。本文就磷丙泊酚二钠的药理学特征、临床应用现状及安全性研究进展进行综述，并对其未来研究方向进行展望，以期为临床合理应用提供参考。
Abstract: Fospropofol disodium is a novel water-soluble prodrug of propofol independently developed in China. It has been approved for the induction and maintenance of general anesthesia in adults, sedation of mechanically ventilated patients in the intensive care unit (ICU), and sedation during non-intubated diagnostic and therapeutic procedures. Following intravenous administration, fospropofol disodium is hydrolyzed by alkaline phosphatase to release the active metabolite propofol, exhibiting pharmacokinetic characteristics such as a relatively gradual onset of action and stable increases in plasma drug concentrations. Compared with conventional lipid-emulsion propofol formulations, fospropofol disodium demonstrates advantages in reducing injection pain and attenuating cardiovascular and respiratory depression. However, its clinical use is still associated with certain limitations, including a delayed onset of action and a relatively high incidence of paresthesia and pruritus. This review summarizes the pharmacological characteristics, current clinical applications, and safety profile of fospropofol disodium, and discusses future research directions, with the aim of providing a reference for its rational clinical use.
文章引用：周思雨, 符磊. 磷丙泊酚二钠的应用现状与研究进展[J]. 临床医学进展, 2026, 16(7): 1439-1447. https://doi.org/10.12677/acm.2026.1672663

参考文献

[1] Bakhtiari, E., Mousavi, S.H. and Gharavi Fard, M. (2021) Pharmacological Control of Pain during Propofol Injection: A Systematic Review and Meta-Analysis. Expert Review of Clinical Pharmacology, 14, 889-899. [Google Scholar] [CrossRef] [PubMed]
[2] Dinis-Oliveira, R.J. (2018) Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects. BioMed Research International, 2018, Article ID: 6852857. [Google Scholar] [CrossRef] [PubMed]
[3] Atlas, G. (2011) Fospropofol: Is There an Infusion Regimen for Propofol Equivalence? Journal of Anaesthesiology Clinical Pharmacology, 27, 303-306. [Google Scholar] [CrossRef] [PubMed]
[4] Abdelmalak, B., Khanna, A. and Tetzlaff, J. (2012) Fospropofol, a New Sedative Anesthetic, and Its Utility in the Perioperative Period. Current Pharmaceutical Design, 18, 6241-6252. [Google Scholar] [CrossRef] [PubMed]
[5] Yen, P., Prior, S., Riley, C., Johnston, W., Smiley, M. and Thikkurissy, S. (2013) A Comparison of Fospropofol to Midazolam for Moderate Sedation during Outpatient Dental Procedures. Anesthesia Progress, 60, 162-177. [Google Scholar] [CrossRef] [PubMed]
[6] Moore, G.D., Walker, A.M. and MacLaren, R. (2009) Fospropofol: A New Sedative-Hypnotic Agent for Monitored Anesthesia Care. Annals of Pharmacotherapy, 43, 1802-1808. [Google Scholar] [CrossRef] [PubMed]
[7] Ilic, R.G. (2015) Fospropofol and Remimazolam. International Anesthesiology Clinics, 53, 76-90. [Google Scholar] [CrossRef] [PubMed]
[8] 何涛, 王永徽, 付静文, 等. 血清碱性磷酸酶水平与择期手术患者磷丙泊酚钠起效时间及不良反应发生率的关系分析[J]. 临床合理用药杂志, 2022, 15(33): 50-52.
[9] Wang, R., Jiang, X., Cao, Q. and Zhang, W. (2025) Pharmacokinetics and Safety of Fospropofol Disodium for Injection in Subjects with Hepatic Impairment Compared with Healthy Matched Controls: A Prospective Cohort Study. Drug Design, Development and Therapy, 19, 9355-9366. [Google Scholar] [CrossRef] 
[10] Lang, B., Yang, J., Wang, Y., Luo, Y., Kang, Y., Liu, J., et al. (2014) An Improved Design of Water-Soluble Propofol Prodrugs Characterized by Rapid Onset of Action. Anesthesia & Analgesia, 118, 745-754. [Google Scholar] [CrossRef] [PubMed]
[11] Levitzky, B.E. and Vargo, J.J. (2008) Fospropofol Disodium Injection for the Sedation of Patients Undergoing Colonoscopy. Therapeutics and Clinical Risk Management, 4, 733-738.
[12] 白清海, 张强, 梁亮亮, 等. 磷丙泊酚二钠与丙泊酚用于消化内镜短小手术麻醉的有效性及安全性比较[J]. 临床医学研究与实践, 2025, 10(11): 82-85.
[13] Yue, F., Shi, X., Ji, R., Wei, Y., Xiao, H., Zhang, H., et al. (2025) Anesthesia Effects of Different Doses of Fospropofol Disodium for Painless Colonoscopy Diagnosis and Treatment. Frontiers in Medicine, 12, Article ID: 1562592. [Google Scholar] [CrossRef] [PubMed]
[14] 胡梦蓉, 黄儒文, 李芮, 等. 磷丙泊酚二钠和丙泊酚对无痛超声引导下经支气管针吸活检术患者全麻期间血流动力学的影响[J]. 实用医学杂志, 2026, 42(3): 525-530.
[15] Silvestri, G.A., Vincent, B.D. and Wahidi, M.M. (2011) Fospropofol Disodium for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy. Journal of Bronchology & Interventional Pulmonology, 18, 15-22. [Google Scholar] [CrossRef] [PubMed]
[16] 汤玮洁, 李薇, 尚子祥, 等. 磷丙泊酚二钠与丙泊酚在宫腔镜检查中镇静效果的比较[J]. 临床麻醉学杂志, 2026, 42(3): 264-268.
[17] 张美玲, 项燚, 崔玲, 等. 磷丙泊酚二钠在妇科无痛宫腔镜检查术麻醉中的应用效果[J]. 中国计划生育学杂志, 2025, 33(12): 2746-2750.
[18] Wu, C.M., Zhang, W.S., Liu, J., Zhang, W.Y. and Ke, B.W. (2021) Efficacy and Safety of Fospropofol Disodium for Injection in General Anesthesia Induction for Adult Patients: A Phase 3 Trial. Frontiers in Pharmacology, 12, Article ID: 687894.
[19] Xu, Y., Liu, Q., Yang, Z., Zhu, L., Jia, X., Guo, H., et al. (2026) Efficacy and Safety of Fospropofol Disodium versus Propofol for General Anesthesia Induction: A Systematic Review and Meta-Analysis. European Journal of Medical Research, 31, Article No. 547. [Google Scholar] [CrossRef] 
[20] Candiotti, K.A., Gan, T.J., Young, C., Bekker, A., Sum-Ping, S.T.J., Kahn, R., et al. (2011) A Randomized, Open-Label Study of the Safety and Tolerability of Fospropofol for Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit. Anesthesia & Analgesia, 113, 550-556. [Google Scholar] [CrossRef] [PubMed]
[21] Gao, X., Gao, C., Fang, X., Ren, L., Zhang, H., Tang, Y., et al. (2025) Fospropofol Disodium versus Propofol for Deep Sedation in Critically Ill Patients: A Randomized Pilot Study. BMC Anesthesiology, 25, Article No. 166. [Google Scholar] [CrossRef] [PubMed]
[22] 李薇, 杨秀丽, 刘伟钜, 等. 不同剂量磷丙泊酚二钠在老年患者全麻诱导期镇静效果的比较[J]. 临床麻醉学杂志, 2025, 41(3): 229-232.
[23] Li, W., Ning, J., Sheng, X., Liu, W., Zhou, Y. and Shen, Q. (2025) Addition of Sufentanil to Fospropofol Disodium during Induction of General Anesthesia Shortens Time to Sedation Onset in Elderly Patients: A Randomized Controlled Trial. BMC Anesthesiology, 25, Article No. 458. [Google Scholar] [CrossRef] 
[24] 王梦媛, 褚文昊, 李文利, 等. 磷丙泊酚二钠及其活性代谢产物在妊娠大鼠体内的药代动力学研究[J]. 中国临床药理学杂志, 2024, 40(23): 3439-3443.
[25] 磷丙泊酚二钠临床应用指导意见专家组, 刘进, 朱涛. 磷丙泊酚二钠临床应用指导意见[J]. 中华麻醉学杂志, 2023, 43(8): 912-915.
[26] Zou, C., Chen, H. and Qiu, Y. (2025) Clinical Use of Fospropofol Disodium: Evaluation of Pharmacology, Safety, and Efficacy. Drug Design, Development and Therapy, 19, 5453-5460. [Google Scholar] [CrossRef] [PubMed]
[27] 张东浩, 李金辉, 班儒孟, 等. 成人择期手术患者全麻诱导和维持中应用磷丙泊酚二钠与丙泊酚的疗效和安全性比较[J]. 吉林大学学报(医学版), 2025, 51(1): 143-149.

为你推荐